[1]
2024. Access to Medicines in Low- and Middle-Income Countries – Is the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to blame?. Ghana Pharmaceutical Journal. 25, 1 (Oct. 2024), 1–9. DOI:https://doi.org/10.38159/q1zweb53.